Addex Therapeutics is a clinical-stage biopharmaceutical/pharmaceutical company focused on the development and commercialization of novel orally available medicines, including allosteric modulation-based drug discovery and development for human health. Its shares trade on the SIX Swiss Exchange under the symbol ADXN.
Focus Areas
Notable Investments
